Mizuho Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Mizuho Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,263	Closed	-$29K	–	669
2016 Q2	$29K	Buy	1,263 +434	+52%	+$14K	0.01%	670
2016 Q1	$53K	Sell	829 -434	-34%	-$17.6K	0.01%	542
2015 Q4	$78K	Hold	1,263	–	–	0.02%	587
2015 Q3	$51K	Buy	1,263 +434	+52%	+$22.5K	0.01%	613
2015 Q2	$48K	Hold	829	–	–	0.01%	619
2015 Q1	$53K	Buy	+829	New	+$56.2K	0.01%	542
2014 Q4	–	Sell	-18,510	Closed	-$718K	–	690
2014 Q3	$718K	Buy	18,510 +4,150	+29%	+$147K	0.15%	152
2014 Q2	$494K	Buy	+14,360	New	+$452K	0.11%	171

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mizuho Asset Management's IONS Position: Q3 2016 in Review

Mizuho Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 1,263 shares — an estimated $29K sold.

Mizuho Asset Management first reported a position in IONS in Q2 2014 and held it in 8 quarters. The position peaked at $718K in Q3 2014. 282 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Mizuho Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Mizuho Asset Management sold 1,263 Ionis Pharmaceuticals shares in Q3 2016, an estimated $29K.
Mizuho Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 8 quarters.
Mizuho Asset Management's Ionis Pharmaceuticals position peaked at $718K in Q3 2014.
282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.